Unlock instant, AI-driven research and patent intelligence for your innovation.

Compound or salt thereof and preparation method and application of same

a technology of compound or salt, applied in the field of compound or salt thereof, can solve the problems of difficult modification, low yield, and difficult to synthesize polypeptide drugs

Pending Publication Date: 2021-09-09
ZHEJIANG PEPTITES BIOTECH CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The invention is a compound represented by Formula (1), which can be used to create a resin. This compound can have various substituents and can be used for various chemical reactions. The technical effect of this invention is the creation of a versatile compound that can be easily attached to a resin and used for various chemical reactions.

Problems solved by technology

However, it is not easy to synthesize polypeptide drugs.
However, some modifications are not easy to accomplish by the solid-phase synthesis method alone, and even if they can be, the yield is not high.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound or salt thereof and preparation method and application of same
  • Compound or salt thereof and preparation method and application of same
  • Compound or salt thereof and preparation method and application of same

Examples

Experimental program
Comparison scheme
Effect test

example 1 preparation

of the Compound of Formula (xii)

[0143]The compound of Formula (xii) was prepared by the following route in this Example:

[0144](1) Preparation of Compound xii-1

[0145]4-methoxysalicylaldehyde (100 g, 657 mmol, 1.0 eq) and K2CO3 (181 g, 1314 mmol, 2.0 eq) were weighed and put in a 1 L reaction vessel, to which THF (3.0 eq, 300 ml) and ethyl 4-bromobutyrate (192 g (141 ml), 985.5 mmol, 1.5 eq) were added, followed by stirring and heating until the reaction was complete. Then post-treatment and MTBE recrystallization followed by drying were carried out to obtain compound A-2-1, 155 g in total (yield: 88.7%, purity: 98.67%).

[0146](2) Preparation of Compound xii-2

[0147]155 g of compound xii-1 was transferred to a 2 L reaction bottle, to which a solution of EtNH2.HCl (59.69 g, 732 mmol, 1.5 eq) and NaBH3CN (92.0 g, 1464 mmol, 3 eq) in MeOH was added, followed by stirring at room temperature for 24 hours. Then NaOH (48.8 g, 1220 mmol, 2.5 eq) was added, followed by stirring for 12 hours. The...

example 2 preparation

of the Compound of Formula (xii)

[0152](1) Preparation of Compound xii-1

[0153]4-methoxysalicylaldehyde (100 g, 657 mmol, 1.0 eq) and K2CO3 (181 g, 1314 mmol, 2.0 eq) were weighed and put in a 1 L reaction vessel, to which THF (3.0 eq, 300 ml) and ethyl 4-bromobutyrate (192 g (141 ml), 985.5 mmol, 1.5 eq) were added, followed by stirring and heating until the reaction was completed. Then post-treatment and MTBE recrystallization followed by drying were carried out to obtain compound xii-1, 159.3 g in total (yield: 89.8%, purity: 98.80%).

[0154](2) Preparation of Compound xii-2

[0155]To the above reaction vessel containing 159.3 g of compound A-2-1, an aqueous solution of NaOH (59.8 g, 1495 mmol, 2.5 eq) in methanol was added, and EtNH2.HCl (73.14 g, 897 mmol, 1.5 eq) and Pd / C (22.2 g) were finally added, followed by pressurization with H2 to 0.2˜20 bar and stirring at room temperature of 25° C. until the reaction was completed. After filtration, removal of Pd / C, and rotary drying of met...

example 3 preparation

of Compound of Formula xiii

[0160]

[0161](1) 4-methoxysalicylaldehyde (100 g, 657 mmol, 1.0 eq) and K2CO3 (181 g, 1314 mmol, 2.0 eq) were weighed and put in a 1 L reaction vessel, to which THF (3.0 eq, 300 ml) and ethyl 4-bromobutyrate (192 g (141 ml), 985.5 mmol, 1.5 eq) were added, followed by stirring and heating until the reaction was completed. Then post-treatment and MTBE recrystallization followed by drying were carried out to obtain compound xii-1, 154.6 g in total (yield: 87.0%, purity: 98.47%).

[0162](2) To the above reaction vessel containing 154.6 g compound xii-1, an aqueous solution of NaOH (58.1 g, 1451.5 mmol, 2.5 eq) in methanol was added, and EtNH2.HCl (71.0 g, 870.9 mmol, 1.5 eq) and Pd / C (22.5 g) were finally added, followed by pressurization with H2 to 0.2-20 bar and stirring at room temperature of 25° C. until the reaction was completed. After filtration, removal of Pd / C, and rotary drying of methanol, the residue was extracted with MTBE once and directly used for...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Login to View More

Abstract

The invention relates to a compound or a salt thereof, a method for preparation thereof, and use thereof, wherein the compound has the structure of Formula (1):the substituents in Formula (1) are as defined in the specification. The compound of Formula (1) or a salt thereof can be attached to a solid-phase resin, on which solid-phase synthesis may be performed.

Description

TECHNICAL FIELD[0001]The present invention relates to a compound or a salt thereof a method for preparation thereof, and use thereof.BACKGROUND ART[0002]The contents in this section only provide background information related to the present invention and does not necessarily belong to the prior art.[0003]The inventors are aware that polypeptide drugs are of important value. For example, leuprorelin acetate, Alarelin, liraglutide, and PMX-53 (the structure of PMX-53 can be seen in EP1017713 or J. Med. Chem. 1999, 42, 1965-1974; Low-Molecular-Weight Peptidic and Cyclic Antagonists of the Receptor for the Complement Factor C5a) have important pharmaceutical uses. However, it is not easy to synthesize polypeptide drugs.[0004]The inventors are also aware that synthesis of polypeptides generally includes the solid-phase synthesis method, liquid-phase synthesis method, solid-liquid combinational synthesis method, etc., among which the solid-phase synthesis is generally the mainstream metho...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K1/10C07D307/79C07C217/90C07K1/06C07K7/23
CPCC07K1/10C07D307/79C07K7/23C07K1/063C07C217/90C08G69/48C07C39/00C07K1/042C07C271/16C07C271/22Y02P20/55
Inventor XING, HAIYINGLIU, ZHIGUOYU, XINYOUCHEN, XIAOHANGWANG, HUIPING
Owner ZHEJIANG PEPTITES BIOTECH CO LTD